Physician profile
Veronica Vittone
NPI 1396181749
$4,295.74
in general payments reported to CMS, 2019-2025
41 companies · $1,195 in 2025
The $1,195 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,011 · 2020: $190 · 2021: $437 · 2022: $183 · 2023: $299 · 2024: $979 · 2025: $1,195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,473.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $599.23 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $582.35 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $344.72 | 2019-2025 | |
| Amgen INC. | $323.78 | 2019-2025 | Repatha, Evenity, Otezla |
| Gilead Sciences, INC. | $214.62 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $203.38 | 2019-2025 | Airsupra, Breztri |
| Viiv Healthcare Company | $196.81 | 2024-2025 | Apretude |
| Boston Scientific Corporation | $140.99 | 2023 | |
| Exact Sciences Corporation | $132.40 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Dynavax Technologies Corporation | $130.10 | 2021-2025 | Heplisav-B |
| Abbott Laboratories | $115.89 | 2023-2025 | Freestyle Libre 3, Freestyle Libre |
| Astellas Pharma US INC | $110.49 | 2019-2024 | Veozah |
| Dexcom, INC. | $102.41 | 2024-2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $102.10 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $94.85 | 2019-2025 | Xifaxan |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Vittone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.